Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chappell

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Neurology|June 12, 2002
A crossover, add-on trial of talampanel in patients with refractory partial seizuresA S Chappell, J W Sander, M J Brodie, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|December 8, 2009
A phase II trial of talampanel in subjects with amyotrophic lateral sclerosisRobert M Pascuzzi, Jeremy Shefner, Amy S Chappell, et al.
Spine|May 13, 2010
Efficacy and safety of duloxetine in patients with chronic low back painVladimir Skljarevski, Durisala Desaiah, Hong Liu-Seifert, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 1, 1995
Erythropoietin exerts transcriptional and translational control over globin synthesis in J2E cellsS J Busfield, D S Chappell, G Jennings, et al.
Seminars in Arthritis and Rheumatism|January 21, 2009
Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgiaPhilip J Mease, I Jon Russell, Daniel K Kajdasz, et al.
Anesthesiology|November 20, 1998
AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humansC N Sang, M P Hostetter, R H Gracely, et al.
Arthritis Care & Research|February 12, 2011
Estimation of minimum clinically important difference for pain in fibromyalgiaPhilip J Mease, Michael Spaeth, Daniel J Clauw, et al.
The Veterinary Record|August 3, 2010
Prevalence of a host-adapted group B Salmonella enterica in harbour porpoises (Phocoena phocoena) from the south-west coast of EnglandN J Davison, V R Simpson, S Chappell, et al.
Journal of Clinical Pharmacology|March 24, 2006
Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjectsS S Jhee, A S Chappell, V Zarotsky, et al.
Pain|April 9, 2008
Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trialJon I Russell, Philip J Mease, Timothy R Smith, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Neurology|June 12, 2002
A crossover, add-on trial of talampanel in patients with refractory partial seizuresA S Chappell, J W Sander, M J Brodie, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|December 8, 2009
A phase II trial of talampanel in subjects with amyotrophic lateral sclerosisRobert M Pascuzzi, Jeremy Shefner, Amy S Chappell, et al.
Spine|May 13, 2010
Efficacy and safety of duloxetine in patients with chronic low back painVladimir Skljarevski, Durisala Desaiah, Hong Liu-Seifert, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 1, 1995
Erythropoietin exerts transcriptional and translational control over globin synthesis in J2E cellsS J Busfield, D S Chappell, G Jennings, et al.
Seminars in Arthritis and Rheumatism|January 21, 2009
Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgiaPhilip J Mease, I Jon Russell, Daniel K Kajdasz, et al.
Anesthesiology|November 20, 1998
AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humansC N Sang, M P Hostetter, R H Gracely, et al.
Arthritis Care & Research|February 12, 2011
Estimation of minimum clinically important difference for pain in fibromyalgiaPhilip J Mease, Michael Spaeth, Daniel J Clauw, et al.
The Veterinary Record|August 3, 2010
Prevalence of a host-adapted group B Salmonella enterica in harbour porpoises (Phocoena phocoena) from the south-west coast of EnglandN J Davison, V R Simpson, S Chappell, et al.
Journal of Clinical Pharmacology|March 24, 2006
Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjectsS S Jhee, A S Chappell, V Zarotsky, et al.
Pain|April 9, 2008
Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trialJon I Russell, Philip J Mease, Timothy R Smith, et al.
Pageof 12